Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:


Guest: Welcome to ChinaBio
® Today!

As a guest to ChinaBio® Today, you have access to summaries of over 3000 articles including our archives.  You can use the Search feature on the left menu bar to find what you're looking for, or you can browse summaries of our articles by the categories listed under Subscriber Articles. You can access any article that is marked as FREE. Or you can subscribe and have access to our entire content.   

Top Stories

>> See all top stories...

Recent Articles

Recent Articles

  Harbin Gloria, WuXi Biologics Sign $818 Million Deal for Ex-China Rights to PD-1 Candidate (in: Deals & Financings)
  Zai Lab Files for $115 Million IPO in the US (in: Deals & Financings)
  Antengene of Shanghai Announces a $21 Million Series A Round (in: Deals & Financings)
  Lilly Asia Ventures Closes Fourth Fund with $450 Million (in: Deals & Financings)
  Shanghai Ankon Raises $100 Million to Market Pill-like Endoscopy Device (in: Deals & Financings)
  Shenzhen Royal Asset to Pay $33 Million for Fibrosis Candidates from Prometic (in: Deals & Financings)
  Week in Review: Zai Lab Targets $1 Billion Valuation in Planned US IPO (in: Week in Review)
  Zai Lab of Shanghai Plans $150 Million IPO in the US (in: Deals & Financings)
  Fosun and Shanghai Pharmas Competing for $700 Million Stake in US-based Arbor (in: Deals & Financings)
  Biocept Raises $2.2 Million from Ally Bridge; Plans China Expansion (in: Deals & Financings)